Atlas Trials

ALK Gene Mutation

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ALK Gene Mutation

RecordFirmDate
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK) (NCT05200481)Intergroupe Francophone de Cancerologie Thoracique2022-05-18
Alectinib Pharmacokinetic in Patients With NSCLC (NCT05713006)Instituto Nacional de Cancerologia de Mexico2022-05-01
A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC (NCT04849273)Turning Point Therapeutics, Inc.2021-07-28
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation (NCT04322890)Hunan Province Tumor Hospital2020-04-16
Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients (NCT04708639)Aarhus University Hospital2019-06-19
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers (NCT03868423)Sameek Roychowdhury2019-03-20
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (NCT03049618)University of Southern California2017-03-10
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy (NCT03042221)University of Colorado, Denver2016-05-10
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings (NCT01700582)Intergroupe Francophone de Cancerologie Thoracique2012-04-01

Track ALK Gene Mutation automatically

Every clearance here is in the API, with alerts when new ones post.